RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
scPharmaceuticals Stock

scPharmaceuticals Debt 2024

scPharmaceuticals Debt

-8 USD

Ticker

SCPH

ISIN

US8106481059

WKN

A2H7XD

In 2024, scPharmaceuticals's total debt was -8 USD, a -76.67% change from the -34.3 USD total debt recorded in the previous year.

scPharmaceuticals Aktienanalyse

What does scPharmaceuticals do?

scPharmaceuticals Inc is a US pharmaceutical company based in Lexington, Massachusetts. The company was founded in 2013 and currently employs over 100 staff members. It specializes in the development and marketing of innovative drugs for chronic diseases. The company's business model focuses on the development of drugs in the areas of cardiovascular, renal function, and infectious diseases. The goal is to provide better treatment options for patients suffering from chronic diseases than current therapies. The company relies on innovative technologies to improve the effectiveness and tolerability of the developed medications. One of scPharmaceuticals' core areas is cardiovascular therapy. The company is working on the development of a drug called Furoscix™ for the treatment of patients with acute heart failure. Furoscix™ is a convenient, portable infusion system that allows patients to receive the medication at home or in an outpatient facility instead of staying in a hospital. Currently, Furoscix™ is in Phase 3 clinical trials, and results are still pending. Another core area for scPharmaceuticals is kidney therapy. The company is developing a drug called SC-001 for the treatment of patients with chronic kidney insufficiency. SC-001 is a novel medication based on innovative technology that allows the body to break down the drug more slowly, leading to a longer duration of action. Together with other products, such as a midazolam nasal spray for sedation during endoscopies or a fentanyl nasal spray for pain management after surgeries, scPharmaceuticals is working to revolutionize drug therapy and improve patients' quality of life. The company's history is marked by various stages of development. In 2014, scPharmaceuticals received funding of $16.8 million from various investors, including venture capital firms and strategic partners from the pharmaceutical and biotech industry. In 2018, the company went public on the Nasdaq stock exchange and sold shares worth approximately $90 million. These financings enabled the clinical development and future marketing of Furoscix™ and other medications. scPharmaceuticals aims to develop innovative solutions for patients with chronic diseases and provide better treatment options. The company works closely with physicians, hospitals, and patient groups to understand and cater to the needs of its user groups. With advanced technology and the latest medical knowledge, scPharmaceuticals is working to develop the medications of the future. scPharmaceuticals ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Debt Details

Understanding scPharmaceuticals's Debt Structure

scPharmaceuticals's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing scPharmaceuticals's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to scPharmaceuticals’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in scPharmaceuticals’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about scPharmaceuticals stock

What is the debt of scPharmaceuticals this year?

scPharmaceuticals has a debt level of -8 USD this year.

What was the debt of scPharmaceuticals compared to the previous year?

The debt of scPharmaceuticals has increased by -76.67% compared to the previous year dropped.

What are the consequences of high debt for investors in scPharmaceuticals?

High debt can pose a risk for investors of scPharmaceuticals, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.

What are the consequences of low debt for investors of scPharmaceuticals?

Low debt means that scPharmaceuticals has a strong financial position and is able to fulfill its obligations without overburdening its finances.

How does an increase in debt from scPharmaceuticals affect the company?

An increase in debt of scPharmaceuticals can adversely affect the financial condition of the company and result in a higher burden on its finances.

How does a reduction of debt of scPharmaceuticals affect the company?

A reduction in debt of scPharmaceuticals can strengthen the company's financial position and improve its ability to meet its financial obligations.

What are some factors that influence the debt of scPharmaceuticals?

Some factors that can influence the debt of scPharmaceuticals include investments, acquisitions, operating costs, and revenue development.

Why are the debts of scPharmaceuticals so important for investors?

The debts of scPharmaceuticals are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.

What strategic measures can scPharmaceuticals take to change the debt?

To change the debt, scPharmaceuticals can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.

How much dividend does scPharmaceuticals pay?

Over the past 12 months, scPharmaceuticals paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, scPharmaceuticals is expected to pay a dividend of 0 USD.

What is the dividend yield of scPharmaceuticals?

The current dividend yield of scPharmaceuticals is .

When does scPharmaceuticals pay dividends?

scPharmaceuticals pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of scPharmaceuticals?

scPharmaceuticals paid dividends every year for the past 0 years.

What is the dividend of scPharmaceuticals?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is scPharmaceuticals located?

scPharmaceuticals is assigned to the 'Health' sector.

Wann musste ich die Aktien von scPharmaceuticals kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of scPharmaceuticals from 9/19/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/19/2024.

When did scPharmaceuticals pay the last dividend?

The last dividend was paid out on 9/19/2024.

What was the dividend of scPharmaceuticals in the year 2023?

In the year 2023, scPharmaceuticals distributed 0 USD as dividends.

In which currency does scPharmaceuticals pay out the dividend?

The dividends of scPharmaceuticals are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The scPharmaceuticals stock can be added to a savings plan with the following providers: Trade Republic

Andere Kennzahlen von scPharmaceuticals

Our stock analysis for scPharmaceuticals Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of scPharmaceuticals Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.